GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 19th Apr 2024 ADXS stock ended at $0.572. This is 0.351% more than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $0.572 to a day high of $0.600.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
2024-01-02 $0.646 $0.700 $0.630 $0.630 4 804
2023-12-29 $0.640 $0.760 $0.630 $0.667 20 635
2023-12-28 $0.650 $0.750 $0.630 $0.750 3 707
2023-12-27 $0.638 $0.680 $0.605 $0.650 6 939
2023-12-26 $0.630 $0.670 $0.600 $0.670 13 852
2023-12-22 $0.630 $0.635 $0.600 $0.630 7 920
2023-12-21 $0.665 $0.665 $0.630 $0.630 8 720
2023-12-20 $0.650 $0.713 $0.650 $0.665 12 670
2023-12-19 $0.650 $0.713 $0.650 $0.650 5 509
2023-12-18 $0.660 $0.715 $0.660 $0.664 3 069
2023-12-15 $0.750 $0.770 $0.625 $0.721 8 965
2023-12-14 $0.760 $0.770 $0.760 $0.760 5 010
2023-12-13 $0.80 $0.80 $0.725 $0.760 10 486
2023-12-12 $0.650 $0.86 $0.650 $0.725 8 995
2023-12-11 $0.650 $0.650 $0.600 $0.638 15 721
2023-12-08 $0.680 $0.693 $0.610 $0.615 1 477
2023-12-07 $0.770 $0.82 $0.720 $0.720 4 719
2023-12-06 $0.725 $0.83 $0.725 $0.797 4 379
2023-12-05 $0.565 $0.89 $0.565 $0.770 4 251
2023-12-04 $0.80 $0.88 $0.80 $0.88 869
2023-12-01 $0.790 $0.85 $0.685 $0.80 4 093
2023-11-30 $0.790 $0.790 $0.790 $0.790 184
2023-11-29 $0.790 $0.80 $0.790 $0.80 3 654
2023-11-28 $0.790 $0.90 $0.790 $0.790 3 649
2023-11-27 $0.82 $0.82 $0.82 $0.82 0
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT